substance p has been researched along with l 733060 in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.38) | 18.2507 |
2000's | 18 (42.86) | 29.6817 |
2010's | 20 (47.62) | 24.3611 |
2020's | 3 (7.14) | 2.80 |
Authors | Studies |
---|---|
Boyce, S; Carlson, E; Hill, RG; Rupniak, NMJ; Webb, JK | 1 |
Carlson, EC; de Felipe, C; Harrison, T; Hunt, S; Oates, B; Owen, S; Rupniak, NM; Seward, E; Wheeldon, A | 1 |
Bredesen, DE; Castro-Obregón, S; Chen, SF; Del Rio, G; Frankowski, H; Nicholls, DG; Rao, RV; Stoka, V; Swanson, RA; Vesce, S | 1 |
Angulo, JA; Cadet, JL; Yu, J | 1 |
Jang, JH; Leem, JW; Nam, TS; Paik, KS | 1 |
Castro, E; Coveñas, R; Muñoz, M; Pérez, A; Rosso, M | 1 |
Guo, ZQ; Huang, PQ; Liu, LX; Ruan, YP | 1 |
Charette, AB; Grenon, M; Lemire, A; Pourashraf, M | 1 |
Fiebich, BL; Heinen, M; Herpfer, I; Kupferschmid, S; Langosch, JM; Lieb, K; Walden, J | 1 |
Coveñas, R; Muñoz, M; Pérez, A; Piruat, JI; Rosso, M; Rosso, R; Zamarriego, C | 1 |
Coveñas, R; Montero, I; Muñoz, M; Pérez, A; Rosso, M; Rosso, R; Soult, JA; Zamarriego, C | 1 |
Fiebich, BL; Hamke, M; Herpfer, I; Lieb, K; Wandelt, C | 1 |
Budai, D; Khasabov, SG; Mantyh, PW; Simone, DA | 1 |
Coveñas, R; González-Moles, MA; Montero, I; Muñoz, M; Robles, MJ; Rosso, M | 1 |
Inoue, T; Ishikawa, T; Kamei, C; Ohtsu, H; Rahman, MA; Yatsuzuka, R | 1 |
Aguilar, FJ; Esteban, F; González-Moles, MA; Muñoz, M; Redondo, M; Rosso, M | 1 |
Kamei, C; Kuyama, S; Ogawa, M; Yokota, E | 1 |
Coveñas, R; Muñoz, M; Robles-Frías, MJ; Rosso, M; Salinas-Martín, MV | 1 |
Dolber, PC; Douglas, KL; Eldaif, BM; Fraser, MO; Jin, H; Nassar, R; Zhang, X | 1 |
Hamity, MV; Hammond, DL; White, SR | 1 |
Alysandratos, KD; Angelidou, A; Asadi, S; Conti, P; Kalogeromitros, D; Kempuraj, D; Leeman, S; Peterson, E; Stavrianeas, N; Tagen, M; Theoharides, TC; Vasiadi, M; Zhang, B | 1 |
Coveñas, R; González-Ortega, A; Muñoz, M | 1 |
Almendro, V; Ametller, E; Casas, I; Fernández-Nogueira, P; García-Recio, S; Gascón, P; Mayordomo, C; Pastor-Arroyo, EM; Vinyals, L | 1 |
Coveñas, R; Rodriguez, FD | 1 |
Fish, EW; Heilig, M; Krouse, MC; Malanga, CJ; Robinson, JE; Thorsell, A | 1 |
Henry, PJ; Mann, TS; Taylor, SJ | 1 |
Aricò, G; Parenti, C; Ronsisvalle, G; Scoto, GM | 1 |
Thornton, E; Vink, R | 1 |
Wang, DH; Wang, Y | 1 |
Carranza, A; Coveñas, R; González-Ortega, A; Muñoz, M; Robles-Frias, MJ; Rosso, M; Salinas-Martín, MV | 1 |
Akiyama, T; Carstens, E; Carstens, MI; Takamori, K; Tominaga, M | 1 |
Almendro, V; Carranza, A; Coveñas, R; Garcia-Recio, S; González-Ortega, A; Muñoz, M; Salinas-Martín, MV | 1 |
Dong, J; Feng, F; Hong, L; Xu, G; Yang, J; Zhang, H | 1 |
Ding, D; Hu, JL; Liu, XP; Ren, H; Wang, JG; Yang, WL; Yu, J; Zhang, L | 1 |
Chang, C; Ling, J; Lv, B; Ping, F; Qian, J; Shang, J; Song, H; Wang, L; Wang, Y; Zhou, J | 1 |
Alevizos, M; Conti, P; Karagkouni, A; Leeman, SE; Norwitz, E; Taracanova, A; Theoharides, TC; Weng, Z | 1 |
Bing, G; Byun, JK; Dang, DK; Hong, JS; Jang, CG; Jeong, JH; Kim, DJ; Kim, HC; Ko, SK; Nah, SY; Shin, EJ; Tran, HQ | 1 |
He, F; Li, Q; Luo, C; Tao, L; Wu, X; Xu, X; Yang, Y; Zhang, Y; Zhang, Z | 1 |
Bonci, A; Demarest, TG; Francis, TC; Shen, H; Yano, H | 1 |
Hatano, M; Kimura, K; Nishida, T; Uchi, SH; Yamada, N; Yanai, R | 1 |
Favila, N; Gurney, K; Overton, PG | 2 |
1 review(s) available for substance p and l 733060
Article | Year |
---|---|
Targeting opioid and neurokinin-1 receptors to treat alcoholism.
Topics: Alcoholism; Animals; Humans; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Opioid Peptides; Piperidines; Receptors, Neurokinin-1; Receptors, Opioid; Substance P | 2011 |
41 other study(ies) available for substance p and l 733060
Article | Year |
---|---|
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.
Topics: Animals; Female; Foot; Formaldehyde; Gerbillinae; Injections; Male; Motor Activity; Neurokinin-1 Receptor Antagonists; Nociceptors; Peptide Fragments; Piperidines; Stereoisomerism; Substance P; Time Factors | 1996 |
Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Buspirone; Diazepam; Dose-Response Relationship, Drug; Female; Fluoxetine; Gene Deletion; Guinea Pigs; Imipramine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Social Isolation; Stress, Psychological; Substance P; Tetrazoles; Vocalization, Animal | 2000 |
A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death.
Topics: Animals; Annexin A5; Apoptosis; Caspase Inhibitors; Caspases; Cell Size; Cells, Cultured; Enzyme Inhibitors; Epithelial Cells; Fetus; Humans; Immunohistochemistry; Kidney; Microscopy, Electron; Neurokinin-1 Receptor Antagonists; Neurons; Piperidines; Prosencephalon; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tryptophan | 2002 |
Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.
Topics: Androstanes; Animals; Autoradiography; Benzimidazoles; Binding Sites; Brain; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fever; Glial Fibrillary Acidic Protein; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Piperidines; Signal Transduction; Substance P; Tyrosine 3-Monooxygenase | 2002 |
Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat.
Topics: Analysis of Variance; Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Functional Laterality; Hyperalgesia; Lumbosacral Region; Male; Pain Measurement; Pain Threshold; Peptide Fragments; Piperidines; Rats; Rats, Sprague-Dawley; Rhizotomy; Spinal Cord Injuries; Statistics, Nonparametric; Substance P; Time Factors | 2004 |
Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Glioma; Humans; Neuroblastoma; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P | 2004 |
A general approach to (5S,6R)-6-alkyl-5-benzyloxy-2-piperidinones: application to the asymmetric syntheses of neurokinin substance P receptor antagonist (-)-L-733,061 and (-)-deoxocassine.
Topics: Catalysis; Combinatorial Chemistry Techniques; HIV Protease Inhibitors; Molecular Structure; Neurokinin-1 Receptor Antagonists; Piperidines; Stereoisomerism; Substance P | 2004 |
Nucleophilic addition to 3-substituted pyridinium salts: expedient syntheses of (-)-L-733,061 and (-)-CP-99,994.
Topics: Molecular Structure; Piperidines; Pyridinium Compounds; Stereoisomerism; Structure-Activity Relationship; Substance P | 2004 |
Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; Guinea Pigs; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Neurokinin-1 Receptor Antagonists; Piperidines; Substance P; Time Factors | 2005 |
The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Division; Cell Line, Tumor; Glioma; Humans; Mitogens; Neuroblastoma; Piperidines; Receptors, Neurokinin-1; Substance P | 2005 |
Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Mitogens; Neurokinin-1 Receptor Antagonists; Piperidines; Retinal Neoplasms; Retinoblastoma; Substance P; Tetrazolium Salts | 2005 |
Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor.
Topics: Animals; Animals, Newborn; Astrocytes; Astrocytoma; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neurokinin-1 Receptor Antagonists; Oligonucleotide Array Sequence Analysis; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Time Factors | 2006 |
NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla.
Topics: Animals; Capsaicin; Electrophysiology; Excitatory Amino Acid Agonists; Extracellular Space; Immunohistochemistry; Iontophoresis; Male; Medulla Oblongata; Microscopy, Confocal; N-Methylaspartate; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 2007 |
Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.
Topics: Apoptosis; Blotting, Western; Cell Count; Cell Proliferation; Child, Preschool; Dose-Response Relationship, Drug; Humans; Immunoenzyme Techniques; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Retinal Neoplasms; Retinoblastoma; Stereoisomerism; Substance P; Tryptophan; Tumor Cells, Cultured | 2007 |
Involvement of chemical mediators in nasal allergic responses of HDC-KO mice.
Topics: Animals; Behavior, Animal; Chlorpheniramine; Histamine H1 Antagonists; Histidine Decarboxylase; Hydantoins; Immunization; Immunoglobulin E; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Ovalbumin; Piperidines; Receptors, Immunologic; Receptors, Prostaglandin; Rhinitis, Allergic, Seasonal; Sneezing; Substance P | 2007 |
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Laryngeal Neoplasms; Mitosis; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan | 2008 |
Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice.
Topics: Animals; Capsaicin; Cetirizine; Disease Models, Animal; Female; Histamine; Histamine Agonists; Histamine H1 Antagonists, Non-Sedating; Imidazoles; Mice; Mice, Inbred BALB C; Ovalbumin; Piperidines; Pyrrolidines; Receptors, Histamine H3; Rhinitis, Allergic, Perennial; Substance P; Thiourea | 2008 |
The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Mitogens; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Stomach Neoplasms; Substance P | 2008 |
Sprouting of substance P-expressing primary afferent central terminals and spinal micturition reflex NK1 receptor dependence after spinal cord injury.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Female; Injections, Spinal; Muscle Contraction; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Piperidines; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Reflex; Spinal Cord Ischemia; Spinal Nerves; Substance P; Time Factors; Urinary Bladder; Urination | 2008 |
Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception.
Topics: Animals; Capsaicin; Central Nervous System Agents; Freund's Adjuvant; Hot Temperature; Male; Medulla Oblongata; Mustard Plant; Neurokinin-1 Receptor Antagonists; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Piperidines; Plant Oils; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Time Factors | 2010 |
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
Topics: Calcium; Cytosol; Humans; Immunohistochemistry; Interleukin-33; Interleukins; Mast Cells; Neurokinin-1 Receptor Antagonists; Piperidines; Psoriasis; RNA, Messenger; Skin; Substance P; Vascular Endothelial Growth Factor A | 2010 |
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Substance P; Tryptophan | 2012 |
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.
Topics: Antibodies; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Lapatinib; Ligands; Male; Neoplasms; Neurokinin-1 Receptor Antagonists; Piperidines; Prostatic Neoplasms; Quinazolines; Receptor, ErbB-2; Receptors, Neurokinin-1; Signal Transduction; Substance P; Trastuzumab | 2012 |
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.
Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Reinforcement, Psychology; Reward; Substance P | 2012 |
Influence of influenza A infection on capsaicin-induced responses in murine airways.
Topics: Animals; Biphenyl Compounds; Bronchoalveolar Lavage Fluid; Capsaicin; Carbachol; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Inflammation; Influenza A virus; Isoproterenol; Leukocytes; Male; Mice; Mice, Inbred BALB C; Models, Biological; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Orthomyxoviridae Infections; Piperidines; Prostaglandin Antagonists; Respiratory Mucosa; Specific Pathogen-Free Organisms; Substance P; Trachea; TRPV Cation Channels; Xanthones | 2012 |
Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
Topics: Animals; Carrageenan; Dose-Response Relationship, Drug; Hyperalgesia; Infusions, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Naloxone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nociception; Pain; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 2012 |
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Cells; Dopaminergic Neurons; Inflammation; Male; Motor Activity; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P; Substantia Nigra; Tryptophan | 2012 |
Role of substance P in renal injury during DOCA-salt hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Hydroxyproline; Hypertension; Isoindoles; Kidney; Male; Mice; Mice, Inbred C57BL; Piperidines; Receptors, Neurokinin-1; Substance P; Telemetry; Time Factors | 2012 |
The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Structure-Activity Relationship; Substance P; Tryptophan; Tumor Cells, Cultured | 2012 |
Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Antirheumatic Agents; Bombesin; Chloroquine; Drug Combinations; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Gastrin-Releasing Peptide; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Neurons; Peptide Fragments; Piperidines; Pruritus; Substance P; Vesicular Glutamate Transport Protein 2 | 2014 |
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Topics: Antineoplastic Agents; Aprepitant; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan | 2014 |
Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Esophageal Neoplasms; Female; Humans; Imidazoles; Lymphatic Metastasis; Male; Mice, Nude; Middle Aged; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Xenograft Model Antitumor Assays | 2015 |
Neurokinin-1 activation affects EGFR related signal transduction in triple negative breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Middle Aged; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Neurokinin-1; RNA Interference; RNA, Small Interfering; Signal Transduction; Substance P; Triple Negative Breast Neoplasms | 2015 |
Neurokinin-1 receptor is a novel positive regulator of Wnt/ β-catenin signaling in melanogenesis.
Topics: Animals; beta Catenin; Cells, Cultured; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3 beta; Humans; Intercellular Signaling Peptides and Proteins; Melanins; Melanocytes; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Phosphorylation; Piperidines; Receptors, Neurokinin-1; Skin; Skin Pigmentation; Substance P; Time Factors; Wnt Signaling Pathway | 2016 |
SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
Topics: Biphenyl Compounds; Cell Line, Tumor; Humans; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Luteolin; MAP Kinase Signaling System; Mast Cells; NF-kappa B; Piperidines; Receptors, Neurokinin-1; Substance P; Tumor Necrosis Factor-alpha | 2017 |
Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Topics: Animals; Dopamine; Dopaminergic Neurons; Dynorphins; Ginsenosides; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Piperidines; Reactive Oxygen Species; Receptors, Neurokinin-1; Receptors, Opioid, kappa; Substance P; Up-Regulation | 2018 |
Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Injuries, Traumatic; Gene Expression Regulation; Gene Knockout Techniques; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Motor Activity; Neurokinin-1 Receptor Antagonists; Neuroprotection; Oxidative Stress; Piperidines; Receptors, Neurokinin-1; Spatial Memory; Substance P | 2019 |
High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs.
Topics: Action Potentials; Animals; Aprepitant; Calcium Signaling; Cholinergic Neurons; Dopaminergic Neurons; Excitatory Postsynaptic Potentials; Interneurons; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Motivation; Neurokinin-1 Receptor Antagonists; Nucleus Accumbens; Photic Stimulation; Piperidines; Receptor, Muscarinic M1; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Neurokinin-1; Substance P | 2019 |
Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.
Topics: Animals; Corneal Injuries; Epithelium, Corneal; Insulin-Like Growth Factor I; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Piperidines; Proto-Oncogene Proteins c-akt; Receptors, Neurokinin-1; Signal Transduction; Substance P; Wound Healing | 2020 |
Blocking NK1 receptors disrupts the sequential and temporal organization of chain grooming in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Grooming; Markov Chains; Neurokinin-1 Receptor Antagonists; Piperidines; Rats; Receptors, Neurokinin-1; Substance P | 2021 |
The NK1 antagonist L-733,060 facilitates sequence learning.
Topics: Animals; Conditioning, Operant; Learning; Piperidines; Rats; Receptors, Neurokinin-1; Reinforcement, Psychology; Reward; Substance P | 2023 |